Navigation Links
Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
Date:7/27/2010

is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration.  Further information on the company is available at www.adeonapharma.com

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding our growing clinical reference laboratory business. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, a failure of our clinical  trials to achieve desired results, a failure of our clinical reference laboratory to continue to grow or a failure to successfully commercialize products and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2009 and any other filings with the SEC. The information
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
2. Omeros Appoints David A. Mann to its Board of Directors
3. RainDance Technologies Appoints Olex Vice President, System Development
4. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
5. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
6. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
7. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
8. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
9. UltraShape Appoints Assaf Eyal as President & CEO
10. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
11. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... California (PRWEB) July 21, 2014 ... County Workforce Investment Board (WIB) and Las Positas ... to provide technical education and hands-on training for ... Engineering Technology Program at Las Positas is ... training needed for engineering technician careers, and establishes ...
(Date:7/21/2014)... College of Arts and Sciences has received a ... nanoparticles. , Mathew M. Maye, associate professor of ... from the National Science Foundation (NSF). The award ... nanostructures, the results of which may impact gas ... , Maye,s approach is novel, in that ...
(Date:7/21/2014)... , July 21, 2014 ... Global & USA Cancer ... and Forecasts ResearchMoz presents this most ... Market   to 2018 (Identification, Technologies, Market Analysis, Competitor ... and Pipeline Analysis. GLOBAL & ...
(Date:7/20/2014)... NSG Precision Cells has been ... spectrophotometer calibration standards for over 50 ... many products that have transformed the spectroscopy world. ... solid-state calibration standards. , NSG’s solid-state calibration standards ... in 2008. NSG started manufacturing UV and ...
Breaking Biology Technology:Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3
... Webcast and Conference Call Scheduled for Tuesday, May 13th at ... Therapeutics, Inc.,(Nasdaq: IMRX ) today announced that the Company ... 13, 2008, at 5:00 p.m. ET to discuss,first quarter 2008 ... ImaRx,s corporate website at, http://www.imarx.com and will be archived ...
... DIEGO, May 7 Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ... ended,March 31, 2008., Total revenues in the first ... in the first quarter of 2007, and included $2.0 ... Ltd,and $0.6 million in patent reimbursements from Arena,s collaborations ...
... augment Quintiles Consulting offerings, RESEARCH TRIANGLE ... today announced that it has signed an ... and market research,consulting firm located in Boston ... The acquisition of Eidetics will strengthen ...
Cached Biology Technology:Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 8Quintiles Signs Agreement to Acquire Eidetics 2
(Date:7/21/2014)... In traditional apple orchards, effective management practices ... to manage competitive vegetation under the trees, ... These factors are further complicated in organic ... and producers need to meet the stringent ... of the National Organic Program. University of ...
(Date:7/21/2014)... scientist has developed a pioneering new way using ... the effect of drugs on the heart without using ... work of Dr Helen Maddock an expert in ... Applied Biological and Exercise Sciences and could lead ... saved and the quality of their treatments improved. , ...
(Date:7/21/2014)... , July 21, 2014 Research and ... of the "Next Generation Biometric Market by ... & Analysis 2014 - 2020" report to ... Biometric technology is the verification of humans by ... palm, signature, vein, and DNA. DNA and vein ...
Breaking Biology News(10 mins):Organic apple orchards benefit from green compost applications 2New technique uses 'simulated' human heart to screen drugs 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 3
... PHILADELPHIA A study published in the December issue ... the American Association for Cancer Research, suggests that selenium, ... may aid in the prevention of high-risk bladder cancer. ... levels in 767 individuals newly diagnosed with bladder cancer ...
... Rods and cones coexist peacefully in healthy retinas. Both types ... signals when they detect light, which is the first step ... a codependent relationship between the two that can be destructive. ... them to the grave, leading to blindness. A new study ...
... examines genetic variants associated with nine metabolic traits and ... a population unselected for current disease. The traits are ... 2 diabetes, blood pressure, inflammation and lipid levels. ... about their health: these data will help researchers to ...
Cached Biology News:Selenium may prevent high risk-bladder cancer 2Progression of retinal disease linked to cell starvation 2Genes for 9 health indicators 2Genes for 9 health indicators 3
... Ion Chromatography requirements, IonQuest will ... The newly developed conductivity detector ... exceptionally ultra-low drift . The ... creates even higher sensitivities for ...
... fast and easy method for the ... from mammalian tissues. Most of the ... outer membranes. The kit contains extraction ... proteome profiling. Also included is a ...
... 2500ml narrow mouth PYREX low form culture flask is ... to volume ratio. This flask has a heavy beaded ... marking spot. The neck O.D. is 38mm and takes ... use this flask on a heat source smaller than ...
... DNA transformation can be difficult to achieve ... presence of one or more restriction and ... that is recognized as "foreign". TypeOne™ Restriction ... transformation efficiencies in bacterial strains with type ...
Biology Products: